Rare diseases
Investigational molecules
Locations
Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
Universitair Medisch Centrum Utrecht is active in studies across solid tumors and blood cancers, with interest in colorectal cancer, head and neck squamous cell carcinoma, endometrial cancer, liver metastases, acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma. Its trial portfolio also includes rare and difficult-to-treat cancers such as parotid gland carcinoma, diffuse midline glioma, and pheochromocytoma.
Research interests extend to sentinel lymph node mapping, imaging-guided treatment selection, and locoregional approaches for advanced malignancy.
Universitair Medisch Centrum Utrecht runs clinical trials in conditions such as Brain injury, Dermatomyositis, Antisynthetase syndrome, Behcet's syndrome, among others.
Clinical trials run by this sponsor – those enrolling participants first.
The NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe Netherlands
BelgiumThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
